Webinars (working copy)

An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.

Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? (January 27, 2021)

Key issues in high integrity tissue acquisition facing community cancer programs. (December 17, 2020)

This two-part series includes webinars developed in conjunction with the multidisciplinary care team who have deep expertise in caring for patients with cSCC as well as high-risk non-melanoma skin cancers.

Gain important and practical information for the assessment of measurable residual disease as part of routine clinical practice for patients with chronic lymphocytic leukemia (CLL).

Download an in-depth analysis of the proposed calendar year 2021 Medicare payment rules, prepared by Teri Bedard, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Coding Strategies, Inc.

Effective communication with patients is key to providing optimal care to patients. Learn the most effective strategies for successful conversation with patients undergoing treatment for multiple myeloma and discover valuable resources that can help.

Learn how to identify key disparities in clinical trial access for patients with multiple myeloma and explore strategies that can help improve access for underserved communities. (October 21, 2020)

Key results from a recent nationwide survey on the role of APs in cancer clinical research. (November 2, 2020)

Practical strategies for increasing health literacy in patients in order to improve healthcare engagement and shared decision-making, with a special focus on eHealth literacy and financial health literacy. (August 20, 2020)

ACCC and legal experts from Hogan Lovells US LLP provided an in-depth analysis of the proposed calendar year (CY) 2021 Hospital Outpatient Prospective Payment System (OPPS) and proposed Physician Fee Schedule (PFS) rules, and a discussion on how the proposed rules may impact your cancer program or practice in the upcoming year. (August 28, 2020)

Discusses how a person-centered organizational culture supports shared decision-making and effective practices that other cancer programs can replicate. (September 3, 2020)

How to frame treatment and supportive care conversations for patients with metastatic cancer. (August 26, 2020)

Explore cultural factors in patient decision-making, including attitudes around health system trust and engagement. (August 13, 2020)

The role and efficacy of Patient Decision Aids in cancer care delivery, along with the impact these tools have on shared decision-making and patient satisfaction. (August 5, 2020)

Discusses the fundamentals of shared decision-making (SDM) in oncology, and practical tips and case studies for integrating SDM principles and processes into clinical practice. (July 30, 2020)

Join Nadine J. Barrett as she details strategies to improve clinical trial accrual for racial and ethnic minorities, as well as other at-risk groups. (July 24, 2020)

Financial advocacy experts will come together to discuss critical financial advocacy tips that can benefit your patients and your cancer program during the economic crisis resulting from the pandemic. (July 29, 2020)

Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Revenue Cycle Coding Strategies, highlights what your cancer program needs to know by discussing the changes to telehealth services, supervision, provider-based designations, and coding for services. (July 10, 2020)

Join Charles Saunders, MD, Chief Executive Officer, and Jennifer Webster, MS, Vice President of Analytics, IntegraConnect, as they present an overview of the current landscape of patient levels and services at cancer programs. (July 10, 2020)